Subtype
Pancreatic Neoplasm
CI-CAN-00001356Explore in graph →
Non-malignant987 active trials8 approved drugs63 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001356Explore in graph →
Clinical trials
4,216 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06323291 | Cancer Coaching and Remote Education for Self-Empowerment (CARES) Study | completed | Early Phase 1 | 20 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 23, 2026 | clinicaltrials |
| NCT05086250 | Feasibility Study of Oral Ketamine Versus Placebo for the Treatment of Anxiety in Patients With Pancreatic Cancer | completed | Early Phase 1 | 12 | Cedars-Sinai Medical CenterOTHER | 1 | Aug 13, 2026 | clinicaltrials |
| NCT03572283 | Bethanechol Prior to Pancreatic Surgery | completed | Early Phase 1 | 17 | Columbia UniversityOTHER | 1 | Jun 5, 2025 | clinicaltrials |
| NCT00902759 | Fatigue and Pancreas and Bile Duct Cancer Study | completed | Early Phase 1 | 100 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER | 1 | May 2, 2025 | clinicaltrials |
| NCT02896907 | Ascorbic Acid and Combination Chemotherapy in Treating Patients With Locally Advanced or Recurrent Pancreatic Cancer That Cannot Be Removed by Surgery | completed | Early Phase 1 | 8 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER | 1 | Apr 30, 2025 | clinicaltrials |
| NCT01821612 | Chemotherapy and Radiation Therapy Before Surgery Followed by Gemcitabine in Treating Patients with Pancreatic Cancer | completed | Early Phase 1 | 23 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jan 13, 2025 | clinicaltrials |
| NCT03153410 | Pilot Study With CY, Pembrolizumab, GVAX, and IMC-CS4 (LY3022855) in Patients With Borderline Resectable Adenocarcinoma of the Pancreas | completed | Early Phase 1 | 11 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Jan 9, 2025 | clinicaltrials |
| NCT04067960 | Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV Cancer | completed | Early Phase 1 | 197 | Mayo ClinicOTHER | 1 | Aug 14, 2024 | clinicaltrials |
| NCT03970252 | Nivolumab in Combination With Chemotherapy Pre-Surgery in Treating Patients With Borderline Resectable Pancreatic Cancer | completed | Early Phase 1 | 28 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Aug 9, 2024 | clinicaltrials |
| NCT02683824 | Integrin Alpha-v-Beta and [18F]-R01-MG-F2 PET/CT in Measuring Response in Patients With Pancreatic Cancer and Healthy Volunteers | completed | Early Phase 1 | 21 | Stanford UniversityOTHER | 1 | Sep 21, 2023 | clinicaltrials |
| NCT02550327 | Gemcitabine, Nab-Paclitaxel, Cisplatin and Anakinra Treatment on Patients With Pancreatic Cancer | completed | Early Phase 1 | 20 | Baylor Research InstituteOTHER | 1 | Jun 22, 2021 | clinicaltrials |
| NCT02153450 | Stereotactic Radiosurgery and Metformin in Patients With Borderline-Resectable or Locally-Advanced Pancreatic Cancer | completed | Early Phase 1 | 8 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 26, 2020 | clinicaltrials |
| NCT01992705 | Borderline Pancreas Study: FOLFIRINOX +SBRT(GCC 1324) | completed | Early Phase 1 | 8 | University of Maryland, BaltimoreOTHER | 1 | Aug 19, 2019 | clinicaltrials |
| NCT02295956 | Preoperative Rehabilitation During Neoadjuvant Therapy for Pancreatic Cancer | completed | Early Phase 1 | 75 | M.D. Anderson Cancer CenterOTHER | 1 | Jun 12, 2019 | clinicaltrials |
| NCT02847000 | p53/p16-Independent Epigenetic Therapy With Oral Decitabine/Tetrahydrouridine for Pancreatic Cancer | completed | Early Phase 1 | 13 | Yogen SaunthararajahOTHER | 1 | Jan 9, 2019 | clinicaltrials |
| NCT02024997 | Improving Pancreas Radiotherapy Plans Using Respiration-driven Anatomic Deformation: A Pilot Study | completed | Early Phase 1 | 15 | Cedars-Sinai Medical CenterOTHER | 1 | Oct 30, 2014 | clinicaltrials |
| NCT00427752 | Abdominal Exploration Without Incisions | completed | Early Phase 1 | 20 | Jeffrey HazeyOTHER | 1 | May 7, 2012 | clinicaltrials |
| NCT00436410 | Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer | completed | Early Phase 1 | 108 | National Institutes of Health Clinical Center (CC)NIH | 1 | May 2, 2012 | clinicaltrials |
Data updated 5 days agoSource updated Sep 23, 2026source: clinicaltrials